NAD+ : Why Your Cellular Energy Collapses After 40

There is a molecule present in every single one of your cells, without exception. It participates in over 500 biochemical reactions. It conditions your energy production, your DNA repair, the regulation of your biological clock and the activation of cellular defense mechanisms against aging. Its name: NAD+, or nicotinamide adenine dinucleotide.

At 20, your cells overflow with it. At 40, you have lost half. At 60, levels may have dropped by 80% compared to your youth.

This decline is not trivial. For contemporary cell biology, it represents one of the most documented mechanisms of human aging — and one of the most studied by geroscience researchers over the past decade.

What is NAD+ and why is it central?

NAD+ is a coenzyme — an auxiliary molecule essential to the functioning of hundreds of enzymes in the body. It operates in two interconvertible forms — NAD+ (oxidized form) and NADH (reduced form) — and it is precisely this back-and-forth that enables electron transfer at the heart of cellular energy production.

Sirtuins (SIRT1 to SIRT7) are NAD+-dependent deacetylases. They regulate gene expression, cellular stress response, DNA repair and mitochondrial biogenesis. Without sufficient NAD+ available, sirtuins cannot function — and their progressive inactivation is associated with accelerated epigenetic aging.

PARPs (Poly ADP-ribose polymerases) massively consume NAD+ to repair DNA breaks. With age, DNA damage accumulates, PARP demand increases, and NAD+ reserves are depleted ever faster.

CD38, an enzyme whose expression increases significantly with age and chronic inflammation, is one of the primary consumers of NAD+ in the aging organism.

The decline curve: data that doesn't lie

One of the most cited studies on this subject, published in Cell Metabolism in 2012 by Johan Auwerx's team at EPFL, demonstrated that NAD+ levels in skeletal muscle of mice drop dramatically with age — and that this drop precedes and predicts mitochondrial dysfunction.

In humans, the data is consistent. The work of Yoshino et al. (Cell Metabolism, 2021) measured a significant reduction in muscle NAD+ levels in postmenopausal women compared to premenopausal women — and showed that NMN supplementation could partially restore these levels.

What strikes researchers is the simultaneity of the decline with other biological markers of aging: the drop in NAD+ coincides with increased chronic inflammation, reduced mitochondrial capacity, deteriorating sleep quality, and slowing DNA repair mechanisms.

This is not a coincidence. It is a biological cascade.

NAD+ precursors: NR and NMN

The body cannot absorb NAD+ directly through oral intake. It must be synthesized inside cells from precursors.

NR (nicotinamide riboside) is a form of vitamin B3 discovered as an effective NAD+ precursor by Charles Brenner in 2004. The landmark study by Trammell et al. (Nature Communications, 2016) demonstrated for the first time in humans that oral NR supplementation significantly increased blood NAD+ levels — with an excellent safety profile.

NMN (nicotinamide mononucleotide) is a precursor located one step further along the biosynthesis pathway. Popularized by the work of David Sinclair at Harvard, it has shown remarkable results in animal models. Human clinical studies have multiplied since 2020.

To date, the body of human clinical data is more substantial for NR, with a longer track record and a better-documented safety profile.

CD38, inflammaging and the vicious cycle of aging

The vicious cycle is thus established: aging generates inflammation → inflammation activates CD38 → CD38 consumes NAD+ → the drop in NAD+ reduces sirtuin activity → less active sirtuins promote further inflammation and cellular senescence.

This mechanism explains why NAD+ decline accelerates after 50 — inflammaging is self-sustaining and amplifies depletion.

In conclusion

NAD+ is not a wellness trend. It is a central molecule in the biochemistry of human aging, whose progressive decline after the thirties represents one of the most documented biological markers in contemporary geroscience.

References: Yoshino et al., Cell Metabolism, 2021 · Trammell et al., Nature Communications, 2016 · Camacho-Pereira et al., Cell Metabolism, 2016 · López-Otín et al., Cell, 2023

This article is published for informational and educational purposes only. It does not constitute medical advice.